PATENT CLAIM ANALYSIS

Application Number: 16242760
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to antibodies and antigen binding fragments thereof which bind to the cytokine receptor IL-22R, particularly human IL-22R. The invention also relates to pharmaceutical compositions comprising said antibodies or antigen binding fragments thereof, and methods of treating psoriasis, psoriatic arthritis or atopic dermatitis.

Claim (Index 46):
The antibody or antigen binding fragment of  claim 23  which contains the hinge region, CH2 domain and/or CH3 domain of a human IgG.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 99.0
- Lexical Diversity: 1.45714
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14163752', '14307515', '14307519', '15390067', '15192020']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8219644204331729
- 35 USC 102 Novelty (BERT): 0.574957423686017
- Combined Prediction Score: 0.7972637207584573
- Mean Citation Score: 496.6810860000001
- Max Citation Score: 521.3358
- Similarity Product: 375.5446926865339

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test